Lamisil

Terbinafine hydrochloride, the active ingredient in Lamisil, is an allylamine antifungal presented as a topical cream for skin use. It treats fungal infections of the skin such as athlete’s foot, ringworm and beard‑area infections in adults and children, providing a convenient over‑the‑counter‑type option for localized therapy.

GNH USA supplies Lamisil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution, ensuring reliable supply chains and compliance with EU pharmacopeial specifications.

Terbinafine is an allylamine antifungal that targets dermatophyte infections of the skin. - Tinea corporis: resolves ring‑shaped body rash caused by dermatophytes. - Tinea cruris: alleviates itching and redness in the groin area. - Tinea pedis: treats athlete’s foot, reducing scaling and discomfort on the feet. - Tinea barbae: clears fungal infection of the beard region, improving skin integrity.

Topical terbinafine may cause local skin reactions and, rarely, systemic adverse events. Common Side Effects: - Burning sensation: mild heat or sting at the application site. - Itching: transient pruritus around the treated area. - Redness: localized erythema that usually resolves. Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Contact dermatitis: intense inflammation and blistering. - Systemic toxicity: rare liver enzyme elevation if absorbed extensively.

When using topical terbinafine, consider the following precautions to ensure safe and effective therapy. - Avoid application on broken skin: do not apply to open wounds or irritated areas. - Limit use to prescribed area: restrict treatment to affected sites to reduce systemic absorption. - Monitor for allergic signs: discontinue if rash, swelling or breathing difficulty occurs. - Use as directed duration: follow healthcare professional’s recommended treatment length to prevent resistance. - Pregnancy and lactation: consult a physician as safety data are limited. - Store at room temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Terbinafine may interact with other medicines; awareness of these interactions helps avoid reduced efficacy or increased toxicity. Major Interactions (Avoid): - Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase systemic terbinafine levels. - Concomitant use with other topical antifungals containing azoles: can heighten local irritation. Moderate Interactions (Monitor Closely): - Warfarin: terbinafine may enhance anticoagulant effect, requiring INR monitoring. - Oral antihistamines: may increase sedation if systemic absorption occurs. - Systemic corticosteroids: may alter immune response, affecting infection control.